- CA$65.77m
- CA$65.20m
- CA$0.16m
- 77
- 27
- 65
- 57
2019 July 31st | R2020 July 31st | 2021 July 31st | R2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23.1 | 22.9 | 24.4 | 0.207 | 0.161 |
Cost of Revenue | |||||
Gross Profit | 5.56 | 5.87 | 7.19 | 0.152 | 0.161 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 26 | 22.8 | 20.9 | 6.67 | -3.7 |
Operating Profit | -2.95 | 0.134 | 3.47 | -6.46 | 3.86 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.44 | -4.79 | 0.342 | -9.46 | 2.47 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.32 | -4 | 0.885 | -8.98 | 0.618 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -8.52 | -4.31 | 0.561 | -4.56 | 16.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.52 | -4.31 | 0.561 | -4.56 | 16.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.083 | -0.032 | -0.009 | -0.05 | -0.027 |